Katrin Offe, Ph.D. - Related publications

Emory University, Atlanta, GA 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
23 most relevant papers in past 60 days:
Year Citation  Score
2022 Frisoni GB, Altomare D, Thal DR, Ribaldi F, van der Kant R, Ossenkoppele R, Blennow K, Cummings J, van Duijn C, Nilsson PM, Dietrich PY, Scheltens P, Dubois B. The probabilistic model of Alzheimer disease: the amyloid hypothesis revised. Nature Reviews. Neuroscience. 23: 53-66. PMID 34815562 DOI: 10.1038/s41583-021-00533-w   
2022 Zamanian J, Khoshbin Z, Abnous K, Taghdisi SM, Hosseinzadeh H, Danesh NM. Current progress in aptamer-based sensing tools for ultra-low level monitoring of Alzheimer's disease biomarkers. Biosensors & Bioelectronics. 197: 113789. PMID 34798498 DOI: 10.1016/j.bios.2021.113789   
2022 Yang Y, Tapias V, Acosta D, Xu H, Chen H, Bhawal R, Anderson ET, Ivanova E, Lin H, Sagdullaev BT, Chen J, Klein WL, Viola KL, Gandy S, Haroutunian V, et al. Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer's disease. Nature Communications. 13: 159. PMID 35013160 DOI: 10.1038/s41467-021-27572-2   
2022 Thuraisingham RA. A kinetic scheme to examine the role of glial cells in the pathogenesis of Alzheimer's disease. Metabolic Brain Disease. PMID 35032278 DOI: 10.1007/s11011-022-00902-z   
2022 Pons V, Rivest S. Targeting Systemic Innate Immune Cells as a Therapeutic Avenue for Alzheimer Disease. Pharmacological Reviews. 74: 1-17. PMID 34987086 DOI: 10.1124/pharmrev.121.000400   
2022 Asih PR, Stefanoska K, Prikas E, Ittner A. High level forebrain expression of active tau kinase p38γ exacerbates cognitive dysfunction in aged APP-transgenic alzheimer's mice. Neuroscience. PMID 35031398 DOI: 10.1016/j.neuroscience.2022.01.005   
2022 Sharma L, Sharma A, Kumar D, Asthana MK, Lalhlenmawia H, Kumar A, Bhattacharyya S, Kumar D. Promising protein biomarkers in the early diagnosis of Alzheimer's disease. Metabolic Brain Disease. PMID 35015199 DOI: 10.1007/s11011-021-00847-9   
2022 Islam S, Sun Y, Gao Y, Nakamura T, Noorani AA, Li T, Wong PC, Kimura N, Matsubara E, Kasuga K, Ikeuchi T, Tomita T, Zou K, Michikawa M. Presenilin is essential for ApoE secretion, a novel role of presenilin involved in Alzheimer's disease pathogenesis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 34987110 DOI: 10.1523/JNEUROSCI.2039-21.2021   
2022 Lee PJ, Tsai CL, Liang CS, Peng GS, Lee JT, Tsai CK, Lin YK, Yang FY. Biomarkers with Plasma Amyloid β and Tau Protein Assayed by Immunomagnetic Reduction in Patients with Amnestic Mild Cognitive Impairment and Alzheimer's Disease. Acta Neurologica Taiwanica. 31: 53-60. PMID 35040113   
2022 Salloway S, Chalkias S, Barkhof F, Burkett P, Barakos J, Purcell D, Suhy J, Forrestal F, Tian Y, Umans K, Wang G, Singhal P, Budd Haeberlein S, Smirnakis K. Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease. Jama Neurology. 79: 13-21. PMID 34807243 DOI: 10.1001/jamaneurol.2021.4161   
2022 Bigley TM, Xiong M, Ali M, Chen Y, Wang C, Serrano JR, Eteleeb A, Harari O, Yang L, Patel SJ, Cruchaga C, Yokoyama WM, Holtzman DM. Murine roseolovirus does not accelerate amyloid-β pathology and human roseoloviruses are not over-represented in Alzheimer disease brains. Molecular Neurodegeneration. 17: 10. PMID 35033173 DOI: 10.1186/s13024-021-00514-8   
2022 Lin L, Hua F, Salinas C, Young C, Bussiere T, Apgar JF, Burke JM, Muralidharan K, Rajagovindan R, Nestorov I. Quantitative systems pharmacology model for Alzheimer's disease to predict effect of aducanumab on brain amyloid. Cpt: Pharmacometrics & Systems Pharmacology. PMID 35029320 DOI: 10.1002/psp4.12759   
2022 Eastman G, Sharlow ER, Lazo JS, Bloom GS, Sotelo-Silveira JR. Transcriptome and Translatome Regulation of Pathogenesis in Alzheimer's Disease Model Mice. Journal of Alzheimer's Disease : Jad. PMID 35034904 DOI: 10.3233/JAD-215357   
2022 Fan D, Li H, Chen D, Chen Y, Yi X, Yang H, Shi Q, Jiao F, Tang Y, Li Q, Wang F, Wang S, Jin R, Zeng F, Wang Y. Chronic hypoperfusion due to intracranial large artery stenosis is not associated with cerebral β-amyloid deposition and brain atrophy. Chinese Medical Journal. PMID 34985014 DOI: 10.1097/CM9.0000000000001918   
2022 Lee SE, Kwon D, Shin N, Kong D, Kim NG, Kim HY, Kim MJ, Choi SW, Kang KS. Accumulation of APP-CTF induces mitophagy dysfunction in the iNSCs model of Alzheimer's disease. Cell Death Discovery. 8: 1. PMID 35013145 DOI: 10.1038/s41420-021-00796-3   
2022 Campos HC, Ribeiro DE, Hashiguchi D, Hukuda DY, Gimenes C, Romariz SAA, Ye Q, Tang Y, Ulrich H, Longo BM. Distinct Effects of the Hippocampal Transplantation of Neural and Mesenchymal Stem Cells in a Transgenic Model of Alzheimer's Disease. Stem Cell Reviews and Reports. PMID 34997526 DOI: 10.1007/s12015-021-10321-9   
2022 Horta-López PH, Mendoza-Franco G, Rodríguez-Cruz F, Torres-Cruz FM, Hernández-Echeagaray E, Jarero-Basulto JJ, Rícny J, Garduño BF, Garcia-Sierra F. Association of α-1-Antichymotrypsin Expression with the Development of Conformational Changes of Tau Protein in Alzheimer's Disease Brain. Neuroscience. PMID 35007692 DOI: 10.1016/j.neuroscience.2022.01.002   
2022 Ferreira CB, Marttinen M, Coelho JE, Paldanius KMA, Takalo M, Mäkinen P, Leppänen L, Miranda-Lourenço C, Fonseca-Gomes J, Tanqueiro SR, Vaz SH, Belo RF, Sebastião AM, Leinonen V, Soininen H, et al. S327 phosphorylation of the presynaptic protein SEPTIN5 increases in the early stages of neurofibrillary pathology and alters the functionality of SEPTIN5. Neurobiology of Disease. 163: 105603. PMID 34954322 DOI: 10.1016/j.nbd.2021.105603   
2022 Jiang Z, Li J, Kong N, Kim JH, Kim BS, Lee MJ, Park YM, Lee SY, Hong SJ, Sul JH. Accurate diagnosis of atopic dermatitis by combining transcriptome and microbiota data with supervised machine learning. Scientific Reports. 12: 290. PMID 34997172 DOI: 10.1038/s41598-021-04373-7   
2022 Wang J, Fan DY, Li HY, He CY, Shen YY, Zeng GH, Chen DW, Yi X, Ma YH, Yu JT, Wang YJ. Dynamic changes of CSF sPDGFRβ during ageing and AD progression and associations with CSF ATN biomarkers. Molecular Neurodegeneration. 17: 9. PMID 35033164 DOI: 10.1186/s13024-021-00512-w   
2022 Reyes-Dumeyer D, Faber K, Vardarajan B, Goate A, Renton A, Chao M, Boeve B, Cruchaga C, Pericak-Vance M, Haines JL, Rosenberg R, Tsuang D, Sweet RA, Bennett DA, Wilson RS, et al. The National Institute on Aging Late-Onset Alzheimer's Disease Family Based Study: A resource for genetic discovery. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34978149 DOI: 10.1002/alz.12514   
2022 Teunissen CE, Verberk IMW, Thijssen EH, Vermunt L, Hansson O, Zetterberg H, van der Flier WM, Mielke MM, Del Campo M. Blood-based biomarkers for Alzheimer's disease: towards clinical implementation. The Lancet. Neurology. 21: 66-77. PMID 34838239 DOI: 10.1016/S1474-4422(21)00361-6   
2022 Fang J, Zhang P, Wang Q, Chiang CW, Zhou Y, Hou Y, Xu J, Chen R, Zhang B, Lewis SJ, Leverenz JB, Pieper AA, Li B, Li L, Cummings J, et al. Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease. Alzheimer's Research & Therapy. 14: 7. PMID 35012639 DOI: 10.1186/s13195-021-00951-z